The compatibility and stability of octreotide acetate in the presence of diamorphine hydrochloride in polypropylene syringes

Palliative Medicine

Volumn 14, Issue 3, 2000, Pages 205-208

  Fielding, H ^a   Kyaterekera, N ^b   Skellern, G G ^b   Tettey, J N ^b   McDade, J R ^a   Msuya, Z ^b   Watson, D G ^b   Urie, J ^c  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c STOBHILL HOSPITAL   (United Kingdom)

Author keywords

Compatability; Diamorphine; Drug combinations; Drug stability; Octreotide

Indexed keywords

DIAMORPHINE; OCTREOTIDE; POLYPROPYLENE;

ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRECIPITATION; SYRINGE; TEMPERATURE;

EID: 0034017843     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1191/026921600666997498     Document Type: Article

References (11)

1. Khoo D, Riley J, Waxman J. Control of emesis in bowel obstruction in terminally ill patients. Lancet 1992; 339: 375-76.
2. Mercadante S, Maddaloni S. Octreotide in the management of inoperable gastrointestinal obstruction in terminal cancer patients. J Pain Symptom Manage 1992; 7: 496-98.
3. Mercadante S, Caraceni A, Simonette M. Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Palliat Med 1993; 7: 295-99.
4. Mercadante S, Kargar J, Nicolosi G. Octreotide may prevent definitive intestinal obstruction. J Pain Symptom Manage 1997; 13: 352-55.
5. Reynolds JEF ed. Martindale: the extra pharmacopoeia, 31st edn. London: The Royal Pharmaceutical Society, 1996: 1289.
6. Mercadante S. The role of Octreotide acetate in palliative care. J Pain Symptom Manage 1994; 9: 406-11.
7. Riley J, Fallon M. Octreotide in terminal malignant obstruction of the gastrointestinal tract. Eur J Palliat Care 1994; 1: 23-25.
8. Ripley RG, Ritchie DJ, Holstad SG. Stability of octreotide acetate in polypropylene syringes at 5 and -20°C. Am J Health Sys Pharm 1995; 52: 1910-11.
9. Kyaterekera N, Tettey JN, Skellern GG et al. Stability of octreotide in the presence of diamorphine hydrochloride. J Pharm Pharmacol 1997; 49: 8.
10. Kyaterekera N, Tettey JN, Skellern GG et al. HPLC determination of octreotide acetate in compound formulations of Sandostatin® and diamorphine hydrochloride. J Pharm Biomed Anal 1999; 21: 327-30.
11. Omar OA, Hoskin PJ, Johnston A, Hanks GW, Turner P. Diamorphine stability in aqueous solution for subcutaneous infusion. J Pharm Pharmacol 1989; 41: 275-77.